North America region is expected to dominate the market share of global urine bags market owing to the increased incidence of targeted diseases such as UI, bladder blockage, urine retention, Benign Prostate Hyperplasia (BPH), and bladder cancer is driving the regional market. Covered Key Players: Romsons, Urocare Products, Inc, ConvaTec, Inc, Polymedicure, Cardinal Health, Teleflex Incorporated, Coloplast Corp, BD, McKesson Medical Surgical, Inc, Amsino International, Inc, Flexicare Medical Ltd, Medline Industries, Inc, Manfred Sauer GmbH and Others.
New York, USA, Sept. 28, 2022 (GLOBE NEWSWIRE) — The Global Urine Bags Market Size was valued at USD 685.1 million in 2021. The market is projected to grow USD 1.9 billion in 2030, at a CAGR of 4.5%. as per the latest research report published by Spherical Insights & Consulting.
Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/1044
The rise in chronic diseases such as diabetes, cancer, and others, as well as an increase in the occurrence of lifestyle-related disorders like gastro esophageal reflux disease (GERD), obesity, belly bags ulcers, and others, will drive the expansion of the urine bags market in the coming years. Increased R&D spending in the development of innovative medical devices such as urine bagss are also expected to promote market growth. The appropriate reimbursement coverage in nominated nations is likely to promote the growth of the urine bags market in the forecast future. Furthermore, technical advancements in capsule endoscopes are expected to accelerate the growth of the urine bags market. Furthermore, an increase in the incidence of colon cancer is expected to stifle the urine bags market’s growth. On the other side, the increasing complexity of smart tablets, which is expected to drive up costs, is expected to fuel the growth of global urine bags market.
Increased efforts by charitable groups and private companies to promote awareness about incontinence care are predicted to boost product demand globally. With the agreement of the International Incontinence Society, the World Federation of Incontinence Patients (WFIP) launched an annual effort called “World Continence Week.” This international campaign raises awareness to urine incontinence, bladder weakness, and other disorders. Rising demand for low-cost urine collection bags and an increase in hospitalizations due to the rising incidence of chronic diseases such as diabetes is propelling the demand of the global urine bags market.
Buy Now Full Report: https://www.sphericalinsights.com/checkout/1044
The disposable segment is expected to dominate the market share of global urine bags market owing to the less transmission of infection. Consumers prefer disposable bags because they are simple to use and maintain. In the case of reusable drainage bags, adequate washing and disinfection in accordance with FDA requirements is critical to avoid infection transmission from one patient to another. The leg bags segment is expected to dominate the market share of global urine bags market owing to COVID-19 is causing an increase in urine incontinence and hospital admissions all over the world. Most patients prefer urinary leg packs because they allow them to move freely and are simple to use. The 500-1000 ml are expected to dominate the market share of global urine bags market. Urinary drainage bags with a capacity of 500-1000 mL are the common size for urinary leg bags. The hospitals segment is expected to dominate the market share of global urine bags market owing to the fact that hospitals have more facilities and healthcare infrastructure than home care settings.
North America region is expected to dominate the market share of global urine bags market owing to the increased incidence of targeted diseases such as UI, bladder blockage, urine retention, Benign Prostate Hyperplasia (BPH), and bladder cancer is driving the regional market. Every year, more than 250,000 people with BPH have surgical procedures, according to the American Academy of Family Physicians (AAFP). However, Asia Pacific is anticipated to be the fastest-growing regional market during the forecast period. The regional market is being driven by the rising prevalence of BPH, spinal cord injury, and UTI. One of the most common infectious disorders in this area is urinary tract infection (UTI). It is linked to high rates of morbidity and mortality, especially in hospitals, and places a huge financial burden on the community.
Inquire Before Buying This Research Report: https://www.sphericalinsights.com/inquiry-before-buying/1044
Browse key industry insights spread across 210 pages with 118 market data tables and figures & charts from the report “Global Urine Bags Market Size, Share, And COVID-19 Impact Analysis, By Usage (Reusable, Disposable), By Product Type (Leg Bags, Belly Bags, Large Bags & Others), By Capacity (0-500 Ml, 501-1000 Ml, 1001-2000 Ml, More Than 2000 Ml, Others), By End User (Hospitals, Clinics, Diagnostic Center, Ambulatory Surgical Centers, Home Care, Others) And By Region (North America, Europe, Asia-Pacific, Latin America, Middle East And Africa) Analysis And Forecast 2021 – 2030”, in detail along with the table of contents
Covered Key Players: Romsons, Urocare Products, Inc, ConvaTec, Inc, Polymedicure, Cardinal Health, Teleflex Incorporated, Coloplast Corp, BD, McKesson Medical Surgical, Inc, Amsino International, Inc, Flexicare Medical Ltd, Medline Industries, Inc, Manfred Sauer GmbH and Others.
Browse Related Report:
Global Medical Document Management Systems Market Size, Share & Trends, COVID-19 Impact Analysis Report, By Solutions (Standalone Medical Document Management Solutions, Document Scanning Software, Electronic Document Management Software, Integrated Medical Document Management Solutions), By Services (Medical Record Scanning and Management Services, Product Support Services, Implementation & Integration Services, Maintenance, Support, and Optimization Services, Training & Education Services), By End Users (Hospitals and Clinics, Insurance Providers, and Other Healthcare Institutions), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030
https://www.sphericalinsights.com/reports/medical-document-management-systems-market
Global Nano Biosensors Market Size, Share & Trends, COVID-19 Impact Analysis Report, By Type (Nanoparticle-Based Sensors, Nanotube-Based Sensors, And Nanowire Based Sensors), By Product (Wearable Biosensors, And Non-Wearable Biosensors), By Industry Vertical (Healthcare, Consumer Electronics, Food & Beverage, Aerospace & Defense, And Others), And By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, And Africa), Analysis And Forecast 2021 – 2030
https://www.sphericalinsights.com/reports/nano-biosensors-market
Global Medical X-Ray Tube Market Size, Share & Trends, COVID-19 Impact Analysis Report, By Type (Stationary Anode Medical X-Ray Tube, And Rotating Anode Medical X-Ray Tube), By Application (Mobile And Small Portable Dental Systems, General Medical Systems, CT Scanning Process, Angiography Systems, Mammography Systems, And Others), And By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, And Africa), Analysis And Forecast 2021 – 2030
https://www.sphericalinsights.com/reports/medical-x-ray-tube-market
Global Biosimilars Market Size, Share & Trends, COVID-19 Impact Analysis Report, By Product (Recombinant Human Growth Hormone (RHGH), Granulocyte Colony-Stimulating Factor, Interferon, And Others), By Manufacturing Type (In-House Manufacturing, And Contract Manufacturing), By Technology (Recombinant DNA, And Monoclonal Antibodies), By Application (Offsite Treatment, Oncology, Chronic Disorder, Autoimmune Disease, And Others) And By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, And Africa), Analysis And Forecast 2021 – 2030
https://www.sphericalinsights.com/reports/biosimilars-market
Global Hybrid Operating Rooms Market Size, Share & Trends, COVID-19 Impact Analysis Report, By Component (Intraoperative diagnostic imaging systems, Operating room fixtures, Surgical instruments, Audio-visual display systems and tools, & Others), By Application (Cardiovascular, Neurosurgical, Thoracic, Orthopedic & Others), By End-User (Hospitals, Ambulatory surgical centers & Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030
https://www.sphericalinsights.com/reports/hybrid-operating-rooms-market
Global Medical Robots Market Size, Share & Trends, COVID-19 Impact Analysis Report, By Offering (Surgical Robots, Rehabilitation Robots, Telemedicine Robots, Pharma Robots, Medical Service Robots, and Others), By Application (Cardiology, Neurology. Laparoscopic, Orthopedic, and Others), By End-User (Hospitals, Ambulatory Surgery Centers, Rehabilitation Centers, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 – 2030
https://www.sphericalinsights.com/reports/medical-robots-market
For More Information On Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Follow Us: LinkedIn | Facebook | Twitter
The Food and Drug Administration granted Amylyx Pharmaceuticals a hard-won approval in ALS treatment, but AMLX stock sank Friday.
In the past two years, biotech companies Moderna (NASDAQ: MRNA) and Novavax (NASDAQ: NVAX) rose to fame thanks to their successful attempts to develop vaccines for COVID-19 and help us end the outbreak. The pandemic isn't over yet, but Moderna and Novavax have given up substantial chunks of their value in the past year. Where does that leave Moderna and Novavax?
Motley Fool contributor Jason Hall talks about why he owns QuantumScape (NYSE: QS) stock. This battery technology innovator could hold the key to solid-state batteries. Find out what these groundbreaking batteries could mean for electric vehicles and more in the video.
Shares of Nano-X Imaging (NASDAQ: NNOX), commonly called Nanox, soared on Wednesday after it revealed it's taken the next step toward commercializing its flagship medical device. As of 12:20 p.m. ET, Nanox stock was up 21%. Nanox had its initial public offering (IPO) in 2020, promising to disrupt the X-ray industry with its digital-3D imaging machines that will be cheaper for doctors to use.
Charles River Laboratories is a pharmaceutical company that specializes in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services. The cutting-edge Massachusetts-based company has been upgraded to a fundamental "buy" recommendation by a sell-side firm with a $240 price target. In the daily bar chart of CRL, below, we can see that the shares have been in a steady downtrend the past 12 months.
Yahoo Finance's Brad Smith breaks down leading business headlines, including leadership changes at Apple and Disney as well as Google winding down its cloud gaming service Stadia.
Exxon is arguing against the push to get energy companies to slow overseas shipments and stash more fuel in storage tanks.
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.
Amylyx (AMLX) obtains the FDA's approval for its oral, fixed-dose combination therapy for treating adults with amyotrophic lateral sclerosis (ALS) after a few roadblocks.
In the weeks after Russia's invasion of Ukraine on Feb. 24, Claudio Descalzi, CEO of Italian energy major Eni, embarked on a whirlwind of trips to gas suppliers in Africa. The visits included meetings with officials in Algeria in February plus talks in Angola, Egypt and Republic of Congo in March, with Descalzi often accompanied by senior Rome officials, according to company and government releases. State-controlled Eni and Italy were able to leverage existing supply relationships with those nations to secure extra gas to replace a large part of the volumes it received from its top supplier Russia.
A local battery startup now has a big-time auto industry partner. General Motors Co. has signed a research-and-development deal with and has invested in OneD Material Inc., the companies announced Thursday. Palo Alto-based OneD has developed a process of increasing battery capacity by adding silicon to their anodes.
European energy ministers approved the main tenets of the plan to counter Moscow’s efforts to deprive the continent of natural gas and hobble its economy, diplomats said.
Life for the car manufacturers is becoming tougher as the economic slowdown worsens. Demand for cars is likely to sharply slow as consumers delay buying a new vehicles. "This is in keeping with our macroeconomic board's reduced forecast for 2.5% global GDP growth this year and 2.1% in 2023 … on the back of substantial inflation, and higher interest rates meant to tame it," Moody's explained.
COPENHAGEN (Reuters) -Maersk will begin to slow the pace of its container ships to lower fuel costs after sailing at full speed to keep up with demand during the pandemic, its chief executive said on Thursday. Copenhagen-based Maersk, a barometer for global trade, expects ocean freight volumes to be flat or lower this year, its CEO Soren Skou said in a Reuters Newsmaker interview, pointing to U.S. consumers buying less and confidence dented by Russia's invasion of Ukraine. As one of the world's biggest shipping companies, Maersk benefited from soaring freight rates following a surge in consumer demand during the pandemic which led to jams at ports.
The restaurant chain is the latest to introduce a subscription model. It isn't the only one.
Biotechnology startup Ventus Therapeutics is licensing its lead research program, a drug candidate for inflammatory disorders, to Novo Nordisk A/S (NYSE: NVO) for an upfront $70 million. The lead experimental drug, dubbed VENT-01, is a small molecule that targets inflammasomes, which are protein complexes in immune system cells that activate inflammatory responses. An inflammasome known as NLRP3 is the focus of Ventus' experimental treatment. NLRP3 is implicated in many diseases, including Alzhe
From upstream activities to midstream, prospects for companies are rosy now, enhancing the outlook for the Zacks Oil & Gas US Integrated industry. COP, OXY, HES and WHD will make the most of the favorable business scenario.
India’s long-promised initiative to lure more manufacturing is gaining traction in industries from cellphones to auto components to pharmaceutical chemicals.
Relvyrio, Amylyx's drug to treat ALS, a neurological disorder without a cure, was approved even though the treatment is very expensive.
The comments by Akio Toyoda come as Toyota faces pressure to show it isn’t falling behind in the industry’s electric-vehicle race.